| Annual Financials | 2023 | 2024 | 2025 | 2026 | TTM |
Revenue  | 16 | 15 | 38 | 38 | 0 |
| Expenses | 15 | 10 | 23 | 20 | 0 |
| EBITDA | 2 | 6 | 15 | 18 | 0 |
| Operating Profit % | 10 % | 37 % | 40 % | 48 % | 0 % |
| Depreciation | 1 | 1 | 1 | 1 | 0 |
| Interest | 1 | 1 | 1 | 2 | 0 |
| Profit Before Tax | 1 | 4 | 13 | 16 | 0 |
| Tax | 0 | 1 | 3 | 4 | 0 |
| Net Profit | 0 | 3 | 10 | 12 | 0 |
| EPS in ₹ | 0.36 | 2.72 | 10.67 | 12.71 | 0.00 |
Bio Medica Laboratories
Bio Medica Laboratories
158.95
+5.45
(3.55%)
Market Cap
199.88 Cr
PE Ratio
16.24
Volume
8,000.00
Day High - Low
159.00 - 154.10
52W High-Low
162.10 - 101.50
Key Fundamentals
Market Cap
199.88 Cr
EPS
12.71
PE Ratio
16.24
PB Ratio
2.62
Book Value
58.61
EBITDA
18.38
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
66.48
Debt to Equity
1.30
Actual
Company News
View All News
Bio Medica Laboratories Limited initiates postal ballot for shareholders to approve the disinvestment of its 51% stake in Vitamax Private Limited, along with enhanced limits for loans and related party transactions.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,990.50 | #1 4,77,587.63 | 41.71 | #1 61,673.90 | 12.69 | #1 11,565 | 25.80 | 66.37 | |
8,056.00 | 2,13,861.49 | 81.06 | 11,067.00 | 13.95 | 2,568 | 13.44 | 82.30 | |
5,122.80 | 1,94,854.84 | 86.65 | 13,886.20 | 20.34 | 2,138 | 3.28 | 64.10 | |
1,473.20 | 1,19,011.77 | 35.29 | 29,044.60 | 2.24 | 3,870 | -39.18 | 61.43 | |
1,126.80 | 1,13,382.45 | 21.72 | 27,657.90 | 17.64 | 5,026 | 7.82 | 53.10 | |
2,415.00 | 1,10,421.66 | #1 20.65 | 29,038.90 | #1 26.75 | 5,356 | 87.72 | 49.50 | |
2,469.60 | 1,01,993.49 | 51.48 | 14,636.40 | 14.85 | 1,938 | 29.13 | 44.89 | |
1,816.20 | 98,048.75 | 88.28 | 6,867.80 | 22.01 | 890 | #1 123.93 | 81.68 | |
1,148.10 | 95,828.36 | 30.00 | 35,058.60 | 3.90 | 4,158 | -69.10 | 28.48 | |
1,580.20 | 90,921.21 | 26.12 | 33,384.70 | 3.21 | 3,376 | 1.99 | 57.35 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
-
Net Income Growth
17.96 %
Cash Flow Change
-326.54 %
ROE
31.38 %
ROCE
82.15 %
EBITDA Margin (Avg.)
19.49 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 18 | 20 | 39 | 58 |
| Fixed Assets | 8 | 9 | 8 | 7 |
| Current Assets | 9 | 11 | 31 | 48 |
| Capital Work in Progress | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 33 |
| Other Assets | 9 | 11 | 31 | 0 |
| Total Equity & Liabilities | 18 | 20 | 39 | 58 |
| Current Liabilities | 10 | 7 | 17 | 14 |
| Non Current Liabilities | 5 | 8 | 7 | 17 |
| Total Equity | 2 | 5 | 15 | 26 |
| Reserve & Surplus | 2 | 5 | 6 | 17 |
| Share Capital | 0 | 0 | 9 | 9 |
Cash Flow
| Cash Flow | 2023 | 2024 | 2025 |
| Net Cash Flow | -2 | 0 | 0 |
| Investing Activities | -2 | -2 | 0 |
| Operating Activities | 2 | 2 | -4 |
| Financing Activities | -2 | -0 | 3 |
Share Holding
| % Holding | Aug 2025 | May 2026 |
| Promoter | 100.00 % | 67.70 % |
| FIIs | 0.00 % | 0.29 % |
| DIIs | 0.00 % | 2.31 % |
| Government | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 21.38 % |
| Others | 0.00 % | 8.33 % |
| No of Share Holders | 0 | 1,195 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 27 Jul 2026 |  Quarterly Result Announcement | NA | 27 Jul 2026 | 140.05 | 138.70 |
Technical Indicators
RSI(14)
Neutral 67.28
ATR(14)
Less Volatile 7.40
STOCH(9,6)
Neutral 70.83
STOCH RSI(14)
Overbought 85.79
MACD(12,26)
Bullish 2.07
ADX(14)
Strong Trend 39.09
UO(9)
Bearish 59.53
ROC(12)
Uptrend And Accelerating 16.11
WillR(14)
Overbought -9.81
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
